Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Kowloon, Hong Kong.
Eye Contact Lens. 2010 Nov;36(6):371-3. doi: 10.1097/ICL.0b013e3181f6bdc2.
To report a case of presumed corneal stromal graft rejection after deep anterior lamellar keratoplasty in a patient with systemic lupus erythematosis (SLE).
Deep anterior lamellar keratoplasty was performed using the "bug bubble" technique in the left eye of a 14-year-old patient with keratoconus. Her medical records revealed a history of SLE that was in remission. Immediate postoperative course was uneventful. A best-corrected visual acuity (BCVA) of 20/40 was achieved at the end of 6 months. She was advised to taper off and stop topical corticosteroids by the end of 9 months. The patient presented with a red eye and reduced vision 11 months after surgery. At the time of presentation, the BCVA was 20/200, and ultrasonic central corneal thickness (CCT) was 792 μm in the operated eye. The anterior chamber was found to be quiet, and posterior segment examination was unremarkable. A diagnosis of presumed immune-mediated corneal stromal graft rejection was made. Treatment was started in the form of 1% prednisolone acetate eye drops every hour and 0.5% moxifloxacin hydrochloride eye drops thrice times daily. Hundred milligrams of methylprednisolone in 150 mL of 20% dextrose was administered intravenously.
At the end of 2 weeks, the corneal edema cleared with a resultant CCT of 618 μm, and the BCVA improved to 20/40.
Deep anterior lamellar keratoplasty does not eliminate the risk of corneal stromal rejection. Our patient had an associated history of SLE, which may necessitate a prolonged topical immunosuppression after corneal transplantation in these cases.
报告 1 例系统性红斑狼疮(SLE)患者行深板层角膜移植术后疑似角膜基质移植排斥反应。
对 1 例圆锥角膜患者的左眼行深板层角膜移植术,采用“虫泡”技术。其病历显示曾患缓解期 SLE。术后早期无并发症。术后 6 个月最佳矫正视力(BCVA)达 20/40。建议患者在术后 9 个月内逐渐减少并停止局部皮质类固醇的使用。术后 11 个月,患者出现眼红和视力下降。就诊时,BCVA 为 20/200,术眼超声中央角膜厚度(CCT)为 792μm。前房安静,眼底检查未见明显异常。诊断为疑似免疫介导的角膜基质移植排斥反应。治疗开始形式为 1%醋酸泼尼松龙滴眼液每小时 1 次和 0.5%盐酸莫西沙星滴眼液每日 3 次。静脉滴注 150ml 20%葡萄糖溶液中 100mg 甲基泼尼松龙。
2 周后,角膜水肿消退,CCT 为 618μm,BCVA 提高至 20/40。
深板层角膜移植术并不能消除角膜基质排斥反应的风险。我们的患者有相关的 SLE 病史,这可能需要在这些情况下角膜移植后进行长期局部免疫抑制治疗。